Mohammed Ghareeb M.D.

   

Current job

  • July 2018- present:

    Associate Professor of Medical Oncology, Hematology and bone marrow transplantation, National Cancer Institute, Cairo University

  • October 2019 – present

    :  Consultant of Hematology at Dar Al-Salam (Harmel) Hospital, MOH, Egypt

Education

  • M.D. in Medical Oncology

    (year 2012)

    • 2009 – 2012:

      Cairo University, National Cancer Institute

    • Title of thesis: (Evaluation of the Efficacy of Treatment Regimens in Metastatic Breast Cancer by the level of Circulating Tumor Cells)
    • Selected for presentation at the 2013 San Antonio Breast Cancer Symposium, December 10- 14, 2013 in San Antonio, Texas

 

  • Master degree in Internal Medicine (year 2008)
    • 2004 – 2008:

      Cairo University, Faculty of Medicine

    • Title of Thesis: “The Prognostic Factors Affecting Induction therapy in Adult AML patients”
    • MBBCh. (Year 2001)
      • 1995 – 2001:

        Cairo University, Faculty of Medicine

      • Excellent grade with Honor Degree
 

Publications

(https://orcid.org/0000-0002-7249-6725)

  1. 1.      Saber, M., Bahnasy, A., El-Zawahry, H., Allahloubi, N., El-Moetii, M., Abd El Fatah, R., … Ghareeb, M

    . (2013). Abstract P1-04-10: Assessment of circulating tumor cells (CTC) by RT/PCR as a surrogate marker for PFS in metastatic breast cancer (MBC). Cancer Research, 73(24 Supplement), P1-04-10-P1-04-10. https://doi.org/10.1158/0008-5472.SABCS13-P1-04-10

  2. 2.      Adnan, S., Kandeel, E. Z.,
    Ghareeb, M

    ., & Eldessouki, I. A. (2015). Analysis of flt3 in Adult AML. Blood, 126(23), 4964 LP-4964. Retrieved from http://www.bloodjournal.org/content/126/23/4964.abstract

  3. 3.      Eldessouki, I. A., Kandeel, E. Z., Adnan, S.,
    Ghareeb, M

    ., Gaber, O., & Khorshid, O. (2015). Taperring Treatment According Minimal Residual Disease. Blood, 126(23), 4960 LP-4960. Retrieved from http://www.bloodjournal.org/content/126/23/4960.abstract

  4. 4.      Ebid, G. T.,
    Ghareeb, M.

    , Salaheldin, O., & Kamel, M. M. (2015). Prevalence of the frequency of JAK2 (V617F) mutation in different myeloproliferative disorders in Egyptian patients. International Journal of Clinical and Experimental Pathology, 8(9).

  5. 5.      Abdulateef, N., Kamel, M., Salaheldin, O., &
    Ghareeb, M.

    (2016). Serum Leptin and Adiponectin Levels in de Novo Acute Myeloid Leukemia Patients: Correlation with Clinical Characteristics. International Blood Research & Reviews, 5(1), 1–8. http://doi.org/10.9734/IBRR/2016/23857

  6. 6.      Ibrahim, I. H., Kamel, M. M., &
    Ghareeb, M

    . (2016). Circulating DNA in Egyptian Women with Breast Cancer. Asian Pacific Journal of Cancer Prevention

    : APJCP, 17(6), 298993. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/27356723
  7. 7.      Rashed R, Mostafaa N, Nabil R,
    Ghareeb M

    , Ibraheem D. Prognostic Relevance of VEGF-A and COX-2 in StageIV Non-Hodgkin’s Lymphoma (NHL) Patients. Cancer Biol. 2016;6(3). doi:10.7537/marscbj060316.01.

  8. 8.     
    Ghareeb M

    , Naser H, El-Gammal M, Zeeneldin A, Bahnacy A, Khaled H. Metformin and response to neoadjuvant chemotherapy in patients with breast cancer. Ann Oncol . 2016;27(suppl 6). doi:10.1093/annonc/mdw365.82

  9. 9.      Shafik, N. F., S. F. Sabet, Y. M. El-Meligui, M. Atef, and
    M. Ghareeb

    , "The expression of Preferentially Expressed Antigen of Melanoma (PRAME) Gne in Acute Myeloid Leukemia", The journal of the Egyptian Society of Haematology and research, vol. 12, issue 1, pp. 1-7, 2016.

  10. 10.  Eissa, D. S., Kandeel, E. Z., &
    Ghareeb, M

    . (2016). Human myeloid inhibitory C-lectin: a highly specific and stable acute myeloid leukemia marker. Hematological Oncology. https://doi.org/10.1002/hon.2352

  11. 11.  Ashmawy, A. M., Elgeshy, K. M., Abdel Salam, E. S. T.,
    Ghareeb, M

    ., Kobaisi, M. H., Amin, H. A. A., … Abdel Wahab, A. H. A. (2017). Crosstalk between liver-related microRNAs and Wnt/β-catenin pathway in hepatocellular carcinoma patients. Arab Journal of Gastroenterology.

  12. 12.  Bahnassy, A. A., Saber, M. M.,
    Mahmoud, M. G

    ., Abdellateif, M. S., Abd El-Mooti Samra, M., Abd El-Fatah, R. M., … Salem, S. E. (2018). The role of circulating tumor cells in metastatic breast cancer: prognostic and predictive value. Molecular Biology Reports, 1–11. https://doi.org/10.1007/s11033-018-4359-5

  13. 13.  Fahim, M. I., Nassar, O. A., Mansour, O. M., Ali, A. M., Mahmoud, A.-M., Hafez, N. H., …
    Ghareeb, M

    . (2019). Hyperthermic Intraperitoneal Chemotherapy as a Treatment for Epithelial Ovarian Cancer. Indian Journal of Surgical Oncology, 1–5. https://doi.org/10.1007/s13193-018-0867-y

  14. 14.  Ibraheem, D., Kamal, A., Fahim, M., Allam, R.,
    Ghareeb, M

    . (2019). Clinico-pathological variables affecting uterine Carcinosarcoma, Egyptian experience, BGICC conference Abstract Book 2019. Tumori Journal, 105(1_suppl), 4–25

    . abstract https://doi.org/10.1177/0300891619826184
  15. 15.  Magdy, M., Abdel Karim, N., Eldessouki, I., Gaber, O., Rahouma, M., &
    Ghareeb, M

    . (2019). Myeloid Sarcoma. Oncology Research and Treatment, 42(4), 1–6. https://doi.org/10.1159/000497210

  16. 16.  Khalifa, M., Allahloubi, N., Salem, S.,
    mahmoud, M.

    , & Zekri, A. (2020). Correlation between Strength of Estrogen Receptor positivity and Outcome of Adjuvant Tamoxifen Therapy in Breast Cancer Patients. Zagazig University Medical Journal, 0(0), 0–0. https://doi.org/10.21608/zumj.2020.31917.1873

  17. 17.  Zayed, R. A., El-Saadany, Z., Raslan, H. N.,
    Ghareeb, M.

    , Ibraheem, D., Rashed, M., Kandil, R., & Abdeldayem, O. Y. (2020). IL-17 A and IL-17 F single nucleotide polymorphisms and acute myeloid leukemia susceptibility and response to induction therapy in Egypt. Meta Gene, 26, 100773. https://doi.org/10.1016/j.mgene.2020.100773

Tourism